<DOC>
	<DOCNO>NCT01200056</DOCNO>
	<brief_summary>While statin treatment may induce plaque regression , effect statin plaque composition vary dos unknown . This study assess effect volumetric virtual histology intravascular ultrasound ( VH-IVUS ) . In prospective , randomize , double-blinded pilot study , statin-naïve patient stable angina require percutaneous coronary intervention ( PCI ) randomize receive 6 month either atorvastatin 10mg 40 mg daily . VH-IVUS perform non-PCI lesion baseline 6 month ; analysis perform core laboratory .</brief_summary>
	<brief_title>Virtual Histology Findings Effects Varying Doses Atorvastatin Treatment</brief_title>
	<detailed_description>Statin therapy , especially intensive dos , beneficial atherosclerotic coronary disease . Detecting subtle plaque regression statin therapy difficult coronary angiogram ; intravascular ultrasound ( IVUS ) far good method . Volumetric IVUS use statin trial evaluate plaque regression . Intensive statin therapy REVERSAL Trial ASTEROID Trial appear achieve good regression outcome . Stable fibrous plaque likely responsible stable ischemia , unstable plaque ( large lipid core , calcify nodule necrotic core ) , thin-cap fibroatheroma , plaque erosion plaque rupture may responsible acute coronary syndrome ( ACS ) . In vivo tissue characterization plaque composition therefore important , yet regard grayscale IVUS insufficient . The development Virtual Histology ( VH ) utilize IVUS generate radiofrequency backscattering signal virtually separate plaque composition 4 component correspond histopathology make possible vivo assessment plaque composition stability . We believe plaque regression VH-IVUS plaque modification statin therapy could statin dose dependent , may affect clinical outcome . This study design prove hypothesis , utilize VH-IVUS . This study first prospective , randomised , double-blinded pilot study design investigate varying statin dose effect plaque regression VH composition modulation . For ethical reason , placebo arm design . Based available data , clinically realistic dos atorvastatin 10mg ( low dose ) 40mg ( moderate dose ) chosen . Only statin-naïve patient without previous history myocardial infarction ( MI ) would select , aim show `` pure '' effect vary dos statin good reveal subtle difference change .</detailed_description>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Patient age 18 85 ( pregnant ) require percutaneous intervention coronary stenosis . Statin naive patient . No history myocardial infarction . Angina free least 8 week . Any history previous statin treatment myocardial infarction Current acute coronary syndrome cardiogenic shock Surgical bypass candidate Chronic total occlusion tortuous calcified artery preclude safe IVUS examination . Patient refuse give write informed consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Volumetric virtual histology intravascular ultrasound .</keyword>
	<keyword>Statin-naive patient .</keyword>
	<keyword>Varying dos atorvastatin .</keyword>
	<keyword>Clinical outcome .</keyword>
</DOC>